ClinicalTrials.govpublic full text
A 16 Week Evaluation of the Novartis Health Management Tool (HMT) in Age Related Macular Degeneration (AMD)
age related macular degeneration (amd), ranibizumab, age related macular degeneration, amd, health management tool, hmt, best corrected visual acuity, investigator's clinical judgement of change, choroidal neovascularization, central retinal subfield thickness, visual function self test, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 805854
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.